Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,311
Closed -$11.5M 145
2025
Q2
$11.5M Sell
14,311
-1,472
-9% -$1.06M 0.03% 383
2025
Q1
$10.5M Sell
15,783
-5,389
-25% -$3.92M 0.03% 376
2024
Q4
$14.7M Sell
21,172
-3,415
-14% -$2.45M 0.04% 322
2024
Q3
$20.5M Buy
24,587
+11,088
+82% +$9.91M 0.06% 273
2024
Q2
$13.8M Buy
13,499
+8,266
+158% +$7.95M 0.04% 336
2024
Q1
$5.08M Buy
5,233
+717
+16% +$636K 0.02% 553
2023
Q4
$3.42M Buy
4,516
+835
+23% +$551K 0.01% 635
2023
Q3
$2.17M Buy
3,681
+783
+27% +$520K 0.01% 695
2023
Q2
$2.1M Buy
2,898
+65
+2% +$44.2K 0.01% 719
2023
Q1
$1.93M Sell
2,833
-50
-2% -$32.1K 0.01% 775
2022
Q4
$1.58M Buy
+2,883
New +$1.51M 0.01% 813
2022
Q2
Sell
-454
Closed -$303K 1114
2022
Q1
$303K Buy
454
+53
+13% +$35.5K ﹤0.01% 1104
2021
Q4
$319K Buy
+401
New +$319K ﹤0.01% 1078

Other funds holding ASML

Axa's ASML Position: Q3 2025 in Review

Axa sold out of ASML (ASML) in Q3 2025, closing a stake of 14,311 shares — an estimated $11.5M sold.

Axa first reported a position in ASML in Q4 2021 and held it in 13 quarters. The position peaked at $20.5M in Q3 2024. 1,786 funds tracked by Wall St. Rank hold ASML as of Q3 2025.

  • Axa reported no remaining ASML position as of Q3 2025 after selling out during the quarter.
  • Axa sold 14,311 ASML shares in Q3 2025, an estimated $11.5M.
  • Axa first reported a position in ASML in Q4 2021 and held it in 13 quarters.
  • Axa's ASML position peaked at $20.5M in Q3 2024.
  • 1,786 funds tracked by Wall St. Rank held ASML as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.